These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22398970)

  • 1. Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.
    Kharasch ED; Whittington D; Ensign D; Hoffer C; Bedynek PS; Campbell S; Stubbert K; Crafford A; London A; Kim T
    Clin Pharmacol Ther; 2012 Apr; 91(4):673-84. PubMed ID: 22398970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytochrome P4502B6 in methadone metabolism and clearance.
    Kharasch ED; Stubbert K
    J Clin Pharmacol; 2013 Mar; 53(3):305-13. PubMed ID: 23361846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.
    Robertson SM; Maldarelli F; Natarajan V; Formentini E; Alfaro RM; Penzak SR
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):513-9. PubMed ID: 18989234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.
    Kharasch ED; Walker A; Whittington D; Hoffer C; Bedynek PS
    Drug Alcohol Depend; 2009 May; 101(3):158-68. PubMed ID: 19232844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).
    Kharasch ED; Bedynek PS; Hoffer C; Walker A; Whittington D
    Anesthesiology; 2012 Feb; 116(2):432-47. PubMed ID: 22273859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of autoinduction of methadone N-demethylation in human hepatocytes.
    Campbell SD; Crafford A; Williamson BL; Kharasch ED
    Anesth Analg; 2013 Jul; 117(1):52-60. PubMed ID: 23733841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir.
    Kharasch ED; Hoffer C; Whittington D; Walker A; Bedynek PS
    Anesthesiology; 2009 Mar; 110(3):660-72. PubMed ID: 19225389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of R-/S-methadone enantiomer concentration ratio in serum of patients treated with either nevirapine or efavirenz.
    Esteban J; Pellín Mde L; Gimeno C; Barril J; Giménez J; Mora E; Garcia-Pérez AG
    Drug Metab Lett; 2008 Dec; 2(4):269-79. PubMed ID: 19356104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.
    Kharasch ED; Stubbert K
    Drug Metab Dispos; 2013 Dec; 41(12):2166-74. PubMed ID: 24067429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.
    Leger P; Dillingham R; Beauharnais CA; Kashuba AD; Rezk NL; Fitzgerald DW; Pape JW; Haas DW
    J Infect Dis; 2009 Sep; 200(6):955-64. PubMed ID: 19659438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
    Gerber JG; Rhodes RJ; Gal J
    Chirality; 2004 Jan; 16(1):36-44. PubMed ID: 14628297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance.
    Kharasch ED; Bedynek PS; Park S; Whittington D; Walker A; Hoffer C
    Clin Pharmacol Ther; 2008 Oct; 84(4):497-505. PubMed ID: 19238655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation.
    Ogburn ET; Jones DR; Masters AR; Xu C; Guo Y; Desta Z
    Drug Metab Dispos; 2010 Jul; 38(7):1218-29. PubMed ID: 20335270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index.
    Jiang F; Desta Z; Shon JH; Yeo CW; Kim HS; Liu KH; Bae SK; Lee SS; Flockhart DA; Shin JG
    Br J Clin Pharmacol; 2013 Jan; 75(1):244-53. PubMed ID: 22554354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2B6 polymorphism and nonnucleoside reverse transcriptase inhibitor plasma concentrations in Chinese HIV-infected patients.
    Chen J; Sun J; Ma Q; Yao Y; Wang Z; Zhang L; Li L; Sun F; Lu H
    Ther Drug Monit; 2010 Oct; 32(5):573-8. PubMed ID: 20625352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
    Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
    J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients.
    Cabrera SE; Santos D; Valverde MP; Domínguez-Gil A; González F; Luna G; García MJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2791-8. PubMed ID: 19433561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans.
    Maimbo M; Kiyotani K; Mushiroda T; Masimirembwa C; Nakamura Y
    Eur J Clin Pharmacol; 2012 Mar; 68(3):267-71. PubMed ID: 21901344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.